Close

Conatus Pharmaceuticals (CNAT) Shares Pop Higher on Positive Zika Virus Mention

Go back to Conatus Pharmaceuticals (CNAT) Shares Pop Higher on Positive Zika Virus Mention

Conatus Pharmaceuticals (CNAT) Gains on WSJ Zika-Related Mention

August 29, 2016 11:58 AM EDT

Conatus Pharmaceuticals (NASDAQ: CNAT) surges following WSJ mention related to Zika. Shares up 15%.

The article discusses liver-disease drug emricasan for use to quell the Zika virus, which Conatus holds several patents on.

LINK

... More